Showing papers by "Cora N. Sternberg published in 1998"
TL;DR: Whether or not one cycle of chemotherapy is sufficient requires further confirmation, particularly in view of the results with carboplatin as compared with cisplatin in patients with advanced NSGCT, which are of interest.
56 citations
TL;DR: Bladder-conserving therapy may be offered to selected patients with invasive bladder cancer as a viable alternative to radical cystectomy and is of interest for elderly patients with poor medical conditions and for younger patients who may prefer to retain their bladders.
Abstract: For patients with invasive bladder cancer, radical cystectomy remains the gold standard of treatment. However, based upon success with combination chemotherapy, physicians have begun to use this modality in an integrated approach with radiotherapy. This approach is of interest for elderly patients with poor medical conditions and for younger patients who may prefer to retain their bladders. Thorough transurethral resection of the bladder followed by chemotherapy with or without radiotherapy has become the focus of several studies. Bladder-conserving therapy may be offered to selected patients with invasive bladder cancer as a viable alternative to radical cystectomy.
2 citations
01 Jan 1998
TL;DR: Bladder cancer is one of the most common malignancies in Western society, especially among cigarette smokers, and some 20% are invasive at the time of initial presentation.
Abstract: Bladder cancer is one of the most common malignancies in Western society, especially among cigarette smokers. The incidence is slowly rising, with 52 900 new cases predicted in the United States in 1996 (Devesa et al. 1995; Paeker et al. 1996). Although most cases are superficial at presentation, a substantial portion of these subsequently progress, while some 20% are invasive at the time of initial presentation.